Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pialoux

Showing results (121-130 of 135) with videos related to

Pageof 14
Sort By:
Gut|October 18, 2000
Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early reportH Zylberberg, Y Benhamou, J L Lagneaux, et al.
The Journal of Antimicrobial Chemotherapy|June 21, 2019
First year of pre-exposure prophylaxis implementation in France with daily or on-demand tenofovir disoproxil fumarate/emtricitabineM Siguier, R Mera, G Pialoux, et al.
HIV Medicine|July 25, 2008
Viral efficacy maintained and safety parameters improved with a reduced dose of stavudine: a pilot studyH Ait-Mohand, M Bonmarchand, M Guiguet, et al.
Antiviral Therapy|July 1, 1997
Reductions in viral load and increases in T lymphocyte numbers in treatment-naive patients with advanced HIV-1 infection treated with ritonavir, zidovudine and zalcitabine triple therapyD Mathez, P Bagnarelli, I Gorin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2009
High rate of virologic suppression with raltegravir plus etravirine and darunavir/ritonavir among treatment-experienced patients infected with multidrug-resistant HIV: results of the ANRS 139 TRIO trialY Yazdanpanah, C Fagard, D Descamps, et al.
Journal of Medical Virology|February 22, 2021
High performance of a novel antigen detection test on nasopharyngeal specimens for diagnosing SARS-CoV-2 infectionL Courtellemont, J Guinard, C Guillaume, et al.
JAMA|January 14, 2000
Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team)D Descamps, P Flandre, V Calvez, et al.
HIV Medicine|February 20, 2009
Liver-related deaths in HIV-infected patients between 1995 and 2005 in the French GERMIVIC Joint Study Group Network (Mortavic 2005 study in collaboration with the Mortalité 2005 survey, ANRS EN19)E Rosenthal, D Salmon-Céron, C Lewden, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 28, 2022
Why are people still dying of drug-susceptible TB in Paris in the 21<sup>st</sup> century?A-L Beaumont, A Doumbia, N Château, et al.
Antimicrobial Agents and Chemotherapy|May 5, 2010
Gag mutations can impact virological response to dual-boosted protease inhibitor combinations in antiretroviral-naïve HIV-infected patientsLucile Larrouy, C Chazallon, R Landman, et al.
Pageof 14

Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
Gut|October 18, 2000
Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early reportH Zylberberg, Y Benhamou, J L Lagneaux, et al.
The Journal of Antimicrobial Chemotherapy|June 21, 2019
First year of pre-exposure prophylaxis implementation in France with daily or on-demand tenofovir disoproxil fumarate/emtricitabineM Siguier, R Mera, G Pialoux, et al.
HIV Medicine|July 25, 2008
Viral efficacy maintained and safety parameters improved with a reduced dose of stavudine: a pilot studyH Ait-Mohand, M Bonmarchand, M Guiguet, et al.
Antiviral Therapy|July 1, 1997
Reductions in viral load and increases in T lymphocyte numbers in treatment-naive patients with advanced HIV-1 infection treated with ritonavir, zidovudine and zalcitabine triple therapyD Mathez, P Bagnarelli, I Gorin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2009
High rate of virologic suppression with raltegravir plus etravirine and darunavir/ritonavir among treatment-experienced patients infected with multidrug-resistant HIV: results of the ANRS 139 TRIO trialY Yazdanpanah, C Fagard, D Descamps, et al.
Journal of Medical Virology|February 22, 2021
High performance of a novel antigen detection test on nasopharyngeal specimens for diagnosing SARS-CoV-2 infectionL Courtellemont, J Guinard, C Guillaume, et al.
JAMA|January 14, 2000
Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team)D Descamps, P Flandre, V Calvez, et al.
HIV Medicine|February 20, 2009
Liver-related deaths in HIV-infected patients between 1995 and 2005 in the French GERMIVIC Joint Study Group Network (Mortavic 2005 study in collaboration with the Mortalité 2005 survey, ANRS EN19)E Rosenthal, D Salmon-Céron, C Lewden, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 28, 2022
Why are people still dying of drug-susceptible TB in Paris in the 21<sup>st</sup> century?A-L Beaumont, A Doumbia, N Château, et al.
Antimicrobial Agents and Chemotherapy|May 5, 2010
Gag mutations can impact virological response to dual-boosted protease inhibitor combinations in antiretroviral-naïve HIV-infected patientsLucile Larrouy, C Chazallon, R Landman, et al.
Pageof 14